STEFFY DAVID L 4
4 · ODYSSEY HEALTHCARE INC · Filed Nov 3, 2009
Insider Transaction Report
Form 4
STEFFY DAVID L
Director
Transactions
- Sale
Common Stock, par value $0.001 per share
2009-10-30$13.96/sh−43,500$607,260→ 326,157 total - Sale
Common Stock, par value $0.001 per share
2009-11-02$13.64/sh−25,891$353,153→ 300,266 total
Holdings
- 8,437
Employee Stock Option (Right to Buy)
Exercise: $1.38From: 2000-11-30Exp: 2010-11-30→ Common Stock (8,437 underlying) - 8,437
Employee Stock Option (Right to Buy)
Exercise: $11.27From: 2002-07-30Exp: 2012-07-30→ Common Stock (8,437 underlying) - 6,300
Employee Stock Option (Right to Buy)
Exercise: $18.76From: 2004-05-29Exp: 2013-05-29→ Common Stock (6,300 underlying) - 5,928
Employee Stock Option (Right to Buy)
Exercise: $16.87From: 2005-05-07Exp: 2014-05-07→ Common Stock (5,928 underlying) - 8,403
Employee Stock Option (Right to Buy)
Exercise: $11.90From: 2006-05-06Exp: 2015-05-06→ Common Stock (8,403 underlying) - 5,817
Employee Stock Option (Right to Buy)
Exercise: $17.19From: 2007-05-05Exp: 2016-05-05→ Common Stock (5,817 underlying)
Footnotes (3)
- [F1]Sales were pursuant to a Rule 10b5-1 plan established by the Reporting Person on March 13, 2009.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.64 to $14.43, inclusive. The reporting person undertakes to provide to Odyssey HealthCare, Inc. ("Odyssey"), any security holder of Odyssey, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.06, inclusive. The reporting person undertakes to provide to Odyssey HealthCare, Inc. ("Odyssey"), any security holder of Odyssey, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.